Chiltern, a global clinical CRO, has acquired Pacific Clinical Research, a pan-Asian CRO based in Singapore. The move allows Chiltern to offer integrated services throughout the Asia-Pacific region and strengthens its oncology and anti-infective offerings.

Pacific Clinical Research founders Robert Teoh, M.D., and Vonny Iskandar join the Chiltern management team as managing director, Asia-Pacific, and vice president, Asia-Pacific, respectively.

The acquisition of Pacific Clinical Research comes after Chiltern's purchase of Ockham, a specialist oncology and resourcing CRO, in July.

Building on Chiltern's existing operations in India, Australia, Singapore and Taiwan, the combined company now adds direct capabilities in Hong Kong, Korea, Malaysia, Philippines and Thailand.